401 related articles for article (PubMed ID: 30851546)
21. Role of anti-Müllerian hormone and testosterone in follicular growth: a cross-sectional study.
Lv PP; Jin M; Rao JP; Chen J; Wang LQ; Huang CC; Yang SQ; Yao QP; Feng L; Shen JM; Feng C
BMC Endocr Disord; 2020 Jul; 20(1):101. PubMed ID: 32641160
[TBL] [Abstract][Full Text] [Related]
22. Anti-Müllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS.
Rudnicka E; Kunicki M; Calik-Ksepka A; Suchta K; Duszewska A; Smolarczyk K; Smolarczyk R
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830389
[TBL] [Abstract][Full Text] [Related]
23. Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern.
Pelusi C; Fanelli F; Pariali M; Zanotti L; Gambineri A; Pasquali R
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1575-82. PubMed ID: 23928669
[TBL] [Abstract][Full Text] [Related]
24. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome.
Yang Z; Zhou W; Zhou C; Zhou Y; Liu X; Ding G; Hu Y; Pan J; Sheng J; Jin L; Huang H
J Steroid Biochem Mol Biol; 2021 Feb; 206():105806. PubMed ID: 33340681
[TBL] [Abstract][Full Text] [Related]
25. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
[TBL] [Abstract][Full Text] [Related]
26. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of diminished ovarian reserve in Chinese women with polycystic ovary syndrome and sensitive diagnostic parameters.
Jin J; Ruan X; Hua L; Tian X; Li Y; Wang L; Mueck AO
Gynecol Endocrinol; 2017 Sep; 33(9):694-697. PubMed ID: 28412857
[TBL] [Abstract][Full Text] [Related]
28. [Effect of follicle stimulating hormone on the secretion of anti-mullerian hormone in the granulosa cells in patients with polycystic ovarian syndrome].
Li Y; Liang XY
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):5-8. PubMed ID: 22455685
[TBL] [Abstract][Full Text] [Related]
29. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
[TBL] [Abstract][Full Text] [Related]
30. [Anti-Mullerian hormone and polycystic ovary syndrome].
Catteau-Jonard S; Dewailly D
Gynecol Obstet Fertil; 2011 Sep; 39(9):514-7. PubMed ID: 21840745
[TBL] [Abstract][Full Text] [Related]
31. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.
Wachs DS; Coffler MS; Malcom PJ; Chang RJ
J Clin Endocrinol Metab; 2007 May; 92(5):1871-4. PubMed ID: 17299061
[TBL] [Abstract][Full Text] [Related]
32. [Clinical therapeutic effects of acupuncture combined with Chinese herbal medicine on infertility of polycystic ovary syndrome in the patients with ovulation induction with letrozole].
Yin Y; Zhang Y; Zhang H; Jiang D; Guo G
Zhongguo Zhen Jiu; 2018 Jan; 38(1):27-32. PubMed ID: 29354933
[TBL] [Abstract][Full Text] [Related]
33. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
Zhang F; Liu XL; Rong N; Huang XW
J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
[TBL] [Abstract][Full Text] [Related]
34. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.
Pigny P; Merlen E; Robert Y; Cortet-Rudelli C; Decanter C; Jonard S; Dewailly D
J Clin Endocrinol Metab; 2003 Dec; 88(12):5957-62. PubMed ID: 14671196
[TBL] [Abstract][Full Text] [Related]
35. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.
Bradbury RA; Lee P; Smith HC
Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):552-557. PubMed ID: 28597496
[TBL] [Abstract][Full Text] [Related]
36. AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.
Calzada M; López N; Noguera JA; Mendiola J; Hernández AI; Corbalán S; Sanchez M; Torres AM
J Obstet Gynaecol; 2019 Nov; 39(8):1130-1136. PubMed ID: 31208261
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of herb-partitioned moxibustion combined with electroacupuncture on polycystic ovary syndrome in patients with symptom pattern of kidney deficiency and phlegm-dampne.
Zhao QY; Sun Y; Zhou J; Gao YL; Ma GZ; Hu ZH; Wang Y; Shi Y
J Tradit Chin Med; 2021 Dec; 41(6):985-993. PubMed ID: 34939397
[TBL] [Abstract][Full Text] [Related]
38. Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS).
Hoyos LR; Visser JA; McLuskey A; Chazenbalk GD; Grogan TR; Dumesic DA
Hum Reprod; 2020 Oct; 35(10):2294-2302. PubMed ID: 32918081
[TBL] [Abstract][Full Text] [Related]
39. Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome.
Sir-Petermann T; Ladrón de Guevara A; Codner E; Preisler J; Crisosto N; Echiburú B; Maliqueo M; Sánchez F; Perez-Bravo F; Cassorla F
Reprod Sci; 2012 Apr; 19(4):383-90. PubMed ID: 22344736
[TBL] [Abstract][Full Text] [Related]
40. Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome.
Guedikian AA; Lee AY; Grogan TR; Abbott DH; Largaespada K; Chazenbalk GD; Dumesic DA
Fertil Steril; 2018 Mar; 109(3):508-515. PubMed ID: 29428312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
